Breakthroughs in Small Animal Imaging_Technical Insights

The Future to Disease Detection and Prevention

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

The small animal imaging or in vivo preclinical imaging market began to come into existence from the early 1990s when scientists studying biology and disease processes realized that clinical image could help them reduce the cost of research and time span of their animal studies. At present, medical imaging is an important tool in research applications focused toward drug discovery/ development and in the understanding of basic pathological physiology, where changes at the cellular or molecular level in animal models must be closely monitored over time. Broadly, the technology can be segmented into optical imaging, micro computed tomography (micro-CT), micro-MRI, nuclear imaging and micro-ultrasonography (micro-USG) imaging modalities. Most common small animal in vivo imaging devices used in pre-clinical applications are optical imaging and nuclear imaging modalities such as micro positron emission tomography (micro-PET) and micro single-photon emission computed tomography (micro-SPECT). Routine application of small animal imaging in bio-distribution and drug development together contributed to almost 70 percent of all application in 2014.

Table of Contents

Executive SummaryResearch ScopeResearch Process MethodologyResearch MethodologyKey FindingsTechnology Snapshots and TrendsTechnology Overview Technology Overview (continued)Technology Overview (continued) Technology Overview (continued)Technology Value ChainTechnology Value Chain (continued)Technology Capability Technology Capability (continued) Impact Assessment and AnalysisMarket Impact of Key Innovations Market Impact of Key Innovations Market Impact of Key Innovations Market ImpactMarket Drivers Market ChallengesDiffusion of Innovation and Needs AssessmentTechnology Adoption Technology AdoptionEnd-User Requirements End-User Requirements (continued)Opportunity Evaluation and RoadmappingEmerging TrendsTechnology RoadmapTechnology RoadmapTechnology RoadmapTechnology RoadmapTechnology RoadmapTechnology Management StrategiesKey PatentsKey PatentsKey Patents (continued)Key Patents (continued)ContactsContactsLegal DisclaimerAppendixAppendixAppendixAppendixThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.